ArticleInvestigational new drugs2005

Flexible heteroarotinoids (Flex-Hets) exhibit improved therapeutic ratios as anti-cancer agents over retinoic acid receptor agonists.

Doris M Benbrook et al.PubMed ↗Publisher ↗

No numbers read from the abstract.